This maturation was primarily observed in CD8+ DCs and CD103+ DCs (cDC1s) (Fig. 2, B and C), which are known for their roles in cross-presenting antigens to MHC class I and facilitating effective CD8+ T cell activation in tumor-draining lymph nodes and tumors (32). The gene discussed is CD8A; the disease is neoplasm.